US5324520A
(en)
*
|
1988-12-19 |
1994-06-28 |
Vipont Pharmaceutical, Inc. |
Intragingival delivery systems for treatment of periodontal disease
|
FR2649321A1
(fr)
*
|
1989-07-07 |
1991-01-11 |
Inst Nat Sante Rech Med |
Compositions a base de derives nucleotidiques, leurs procedes de preparation, et leurs utilisations notamment en tant que compositions pharmaceutiques
|
US5439688A
(en)
*
|
1989-07-28 |
1995-08-08 |
Debio Recherche Pharmaceutique S.A. |
Process for preparing a pharmaceutical composition
|
US5268178A
(en)
*
|
1989-09-25 |
1993-12-07 |
The Board Of Regents, The University Of Texas System |
Biodegradable antibiotic implants and methods of their use in treating and preventing infections
|
FR2654337B1
(fr)
*
|
1989-11-15 |
1994-08-05 |
Roussel Uclaf |
Nouvelles microspheres injectables biodegradables procede de preparation et suspensions injectables les renfermant.
|
EP0438929B1
(de)
*
|
1990-01-22 |
1993-09-29 |
Eurogentec S.A. |
Mittel auf Somatotropinbasis zur Steuerung der Meereswasseradaptation von Zuchtlachsen
|
US5478564A
(en)
*
|
1990-02-22 |
1995-12-26 |
Teva Pharmaceutical Industries, Ltd. |
Preparation of microparticles for controlled release of water-soluble substances
|
FR2659554B1
(fr)
*
|
1990-03-16 |
1994-09-30 |
Oreal |
Composition pour le traitement cosmetique et/ou pharmaceutique des couches superieures de l'epiderme par application topique sur la peau et procede de preparation correspondant.
|
WO1992000718A1
(en)
*
|
1990-07-03 |
1992-01-23 |
Vipont Pharmaceutical, Inc. |
Intragingival delivery systems for treatment of periodontal disease
|
CA2046830C
(en)
*
|
1990-07-19 |
1999-12-14 |
Patrick P. Deluca |
Drug delivery system involving inter-action between protein or polypeptide and hydrophobic biodegradable polymer
|
US5447728A
(en)
*
|
1992-06-15 |
1995-09-05 |
Emisphere Technologies, Inc. |
Desferrioxamine oral delivery system
|
US5443841A
(en)
*
|
1992-06-15 |
1995-08-22 |
Emisphere Technologies, Inc. |
Proteinoid microspheres and methods for preparation and use thereof
|
US5629020A
(en)
|
1994-04-22 |
1997-05-13 |
Emisphere Technologies, Inc. |
Modified amino acids for drug delivery
|
US6099856A
(en)
|
1992-06-15 |
2000-08-08 |
Emisphere Technologies, Inc. |
Active agent transport systems
|
US5578323A
(en)
*
|
1992-06-15 |
1996-11-26 |
Emisphere Technologies, Inc. |
Proteinoid carriers and methods for preparation and use thereof
|
US6331318B1
(en)
|
1994-09-30 |
2001-12-18 |
Emisphere Technologies Inc. |
Carbon-substituted diketopiperazine delivery systems
|
US5451410A
(en)
*
|
1993-04-22 |
1995-09-19 |
Emisphere Technologies, Inc. |
Modified amino acids for encapsulating active agents
|
US5693338A
(en)
*
|
1994-09-29 |
1997-12-02 |
Emisphere Technologies, Inc. |
Diketopiperazine-based delivery systems
|
US5541155A
(en)
*
|
1994-04-22 |
1996-07-30 |
Emisphere Technologies, Inc. |
Acids and acid salts and their use in delivery systems
|
US6221367B1
(en)
|
1992-06-15 |
2001-04-24 |
Emisphere Technologies, Inc. |
Active agent transport systems
|
US5714167A
(en)
|
1992-06-15 |
1998-02-03 |
Emisphere Technologies, Inc. |
Active agent transport systems
|
US5238714A
(en)
*
|
1990-10-02 |
1993-08-24 |
Board Of Regents, The University Of Texas System |
Efficient microcapsule preparation and method of use
|
US5484584A
(en)
*
|
1990-10-02 |
1996-01-16 |
Board Of Regents, The University Of Texas System |
Therapeutic and diagnostic use of modified polymeric microcapsules
|
IT1247472B
(it)
*
|
1991-05-31 |
1994-12-17 |
Fidia Spa |
Processo per la preparazione di microsfere contenenti componenti biologicamente attivi.
|
WO1993000050A1
(en)
*
|
1991-06-21 |
1993-01-07 |
Genetics Institute, Inc. |
Pharmaceutical formulations of osteogenic proteins
|
CH683149A5
(fr)
*
|
1991-07-22 |
1994-01-31 |
Debio Rech Pharma Sa |
Procédé pour la préparation de microsphères en matériau polymère biodégradable.
|
ES2034891B1
(es)
*
|
1991-08-08 |
1993-12-16 |
Cusi Lab |
Procedimiento de elaboracion en continuo de sistemas coloidales dispersos, en forma de nanocapsulas o nanoparticulas.
|
JPH0539381A
(ja)
*
|
1991-08-08 |
1993-02-19 |
Mitsui Toatsu Chem Inc |
生分解性ポリマー組成物
|
WO1993015722A1
(en)
*
|
1992-02-07 |
1993-08-19 |
Syntex (Usa) Inc. |
Controlled delivery of pharmaceuticals from preformed porous microparticles
|
US5912015A
(en)
|
1992-03-12 |
1999-06-15 |
Alkermes Controlled Therapeutics, Inc. |
Modulated release from biocompatible polymers
|
US5429822A
(en)
*
|
1992-03-13 |
1995-07-04 |
Cambridge Scientific, Inc. |
Biodegradable bursting release system
|
US5811127A
(en)
|
1992-06-15 |
1998-09-22 |
Emisphere Technologies, Inc. |
Desferrioxamine oral delivery system
|
US5792451A
(en)
|
1994-03-02 |
1998-08-11 |
Emisphere Technologies, Inc. |
Oral drug delivery compositions and methods
|
DE4223169C1
(de)
*
|
1992-07-10 |
1993-11-25 |
Ferring Arzneimittel Gmbh |
Verfahren zur Mikroverkapselung wasserlöslicher Wirkstoffe
|
JP2651320B2
(ja)
*
|
1992-07-16 |
1997-09-10 |
田辺製薬株式会社 |
徐放性マイクロスフェア製剤の製造方法
|
FR2693905B1
(fr)
*
|
1992-07-27 |
1994-09-02 |
Rhone Merieux |
Procédé de préparation de microsphères pour la libération prolongée de l'hormone LHRH et ses analogues, microsphères et formulations obtenues.
|
US5922340A
(en)
*
|
1992-09-10 |
1999-07-13 |
Children's Medical Center Corporation |
High load formulations and methods for providing prolonged local anesthesia
|
US5670173A
(en)
*
|
1992-09-14 |
1997-09-23 |
Mcgill University |
Biodegradable polymer membrane containing hemoglobin for blood substitute
|
EP0595030A3
(de)
*
|
1992-10-01 |
1995-06-07 |
Tanabe Seiyaku Co |
Mehrkern-Mikrosphären mit verzögerter Wirkstoffabgabe und Verfahren zu deren Herstellung.
|
HU221308B1
(en)
*
|
1992-10-26 |
2002-09-28 |
Sanol Arznei Schwarz Gmbh |
Process for producing microcapsules
|
US5310742A
(en)
*
|
1992-11-30 |
1994-05-10 |
Elias Alan N |
Uses for thioureylenes
|
JPH08503950A
(ja)
|
1992-12-02 |
1996-04-30 |
アルカーメス・コントロールド・セラピユーテイクス・インコーポレーテツド |
徐放性成長ホルモン含有マイクロスフェア
|
US5401516A
(en)
*
|
1992-12-21 |
1995-03-28 |
Emisphere Technologies, Inc. |
Modified hydrolyzed vegetable protein microspheres and methods for preparation and use thereof
|
AU671536B2
(en)
*
|
1993-02-23 |
1996-08-29 |
Warner-Lambert Company |
A process for the preparation of substantially alcohol free pharmaceutical compositions
|
PT686045E
(pt)
*
|
1993-02-23 |
2001-04-30 |
Genentech Inc |
Estabilizacao por excipientes de polipeptidos tratados com solventes organicos
|
US6090925A
(en)
|
1993-03-09 |
2000-07-18 |
Epic Therapeutics, Inc. |
Macromolecular microparticles and methods of production and use
|
US5981719A
(en)
|
1993-03-09 |
1999-11-09 |
Epic Therapeutics, Inc. |
Macromolecular microparticles and methods of production and use
|
ZA939608B
(en)
*
|
1993-04-22 |
1994-08-24 |
Emisphere Tech Inc |
Modified hydrolyzed vegetable protein microspheres and methods for preparation and use thereof.
|
US5709861A
(en)
*
|
1993-04-22 |
1998-01-20 |
Emisphere Technologies, Inc. |
Compositions for the delivery of antigens
|
ES2163444T3
(es)
*
|
1993-04-22 |
2002-02-01 |
Emisphere Tech Inc |
Composiciones y metodos para la administracion oral de farmacos.
|
US6610329B2
(en)
*
|
1993-04-22 |
2003-08-26 |
Emisphere Technologies Inc. |
Compositions for the delivery of antigens
|
US5643957A
(en)
|
1993-04-22 |
1997-07-01 |
Emisphere Technologies, Inc. |
Compounds and compositions for delivering active agents
|
US5958457A
(en)
|
1993-04-22 |
1999-09-28 |
Emisphere Technologies, Inc. |
Compositions for the delivery of antigens
|
US5603960A
(en)
*
|
1993-05-25 |
1997-02-18 |
O'hagan; Derek T. |
Preparation of microparticles and method of immunization
|
GB9310781D0
(en)
*
|
1993-05-25 |
1993-07-14 |
Davis Stanley S |
Preparation of microparticles
|
US5773025A
(en)
|
1993-09-09 |
1998-06-30 |
Edward Mendell Co., Inc. |
Sustained release heterodisperse hydrogel systems--amorphous drugs
|
US5455046A
(en)
*
|
1993-09-09 |
1995-10-03 |
Edward Mendell Co., Inc. |
Sustained release heterodisperse hydrogel systems for insoluble drugs
|
US6726930B1
(en)
*
|
1993-09-09 |
2004-04-27 |
Penwest Pharmaceuticals Co. |
Sustained release heterodisperse hydrogel systems for insoluble drugs
|
US6080429A
(en)
*
|
1993-10-25 |
2000-06-27 |
Genentech, Inc. |
Method for drying microspheres
|
US6913767B1
(en)
|
1993-10-25 |
2005-07-05 |
Genentech, Inc. |
Compositions for microencapsulation of antigens for use as vaccines
|
US5650173A
(en)
*
|
1993-11-19 |
1997-07-22 |
Alkermes Controlled Therapeutics Inc. Ii |
Preparation of biodegradable microparticles containing a biologically active agent
|
CA2190121A1
(en)
*
|
1994-03-15 |
1995-09-21 |
Edith Mathiowitz |
Polymeric gene delivery system
|
IE940292A1
(en)
*
|
1994-04-06 |
1995-10-18 |
Elan Corp Plc |
Biodegradable microcapsules and method for their manufacture
|
US5626862A
(en)
|
1994-08-02 |
1997-05-06 |
Massachusetts Institute Of Technology |
Controlled local delivery of chemotherapeutic agents for treating solid tumors
|
US5989539A
(en)
|
1995-03-31 |
1999-11-23 |
Emisphere Technologies, Inc. |
Compounds and compositions for delivering active agents
|
US5965121A
(en)
|
1995-03-31 |
1999-10-12 |
Emisphere Technologies, Inc. |
Compounds and compositions for delivering active agents
|
BR9604880A
(pt)
|
1995-03-31 |
1998-05-19 |
Emisphere Tech Inc |
Composto composição forma de unidade de dosagem métodos para administração de um agente biologicamente ativo para preparar uma composição para administração de um agente ativo e para preparar um composto e composição farmacológica
|
US5650386A
(en)
*
|
1995-03-31 |
1997-07-22 |
Emisphere Technologies, Inc. |
Compositions for oral delivery of active agents
|
US6090958A
(en)
|
1995-03-31 |
2000-07-18 |
Emisphere Technologies, Inc. |
Compounds and compositions for delivering active agents
|
US5866536A
(en)
|
1995-03-31 |
1999-02-02 |
Emisphere Technologies, Inc. |
Compounds and compositions for delivering active agents
|
US6001347A
(en)
|
1995-03-31 |
1999-12-14 |
Emisphere Technologies, Inc. |
Compounds and compositions for delivering active agents
|
US5820881A
(en)
*
|
1995-04-28 |
1998-10-13 |
Emisphere Technologies, Inc. |
Microspheres of diamide-dicarboxylic acids
|
US5667806A
(en)
*
|
1995-06-07 |
1997-09-16 |
Emisphere Technologies, Inc. |
Spray drying method and apparatus
|
US6051258A
(en)
|
1995-06-07 |
2000-04-18 |
Emisphere Technologies, Inc. |
Proteinoid emulsions and methods for preparation and use thereof
|
US5750147A
(en)
|
1995-06-07 |
1998-05-12 |
Emisphere Technologies, Inc. |
Method of solubilizing and encapsulating itraconazole
|
US5824345A
(en)
*
|
1995-06-07 |
1998-10-20 |
Emisphere Technologies, Inc. |
Fragrances and flavorants
|
CN1069827C
(zh)
*
|
1995-06-09 |
2001-08-22 |
浙江大学 |
一种多肽蛋白质药物微球的制备方法
|
CN1156961A
(zh)
|
1995-06-09 |
1997-08-13 |
欧罗赛铁克股份有限公司 |
产生长效局部麻醉的制剂和方法
|
US6265389B1
(en)
|
1995-08-31 |
2001-07-24 |
Alkermes Controlled Therapeutics, Inc. |
Microencapsulation and sustained release of oligonucleotides
|
JP2000507912A
(ja)
*
|
1995-08-31 |
2000-06-27 |
アルカームズ コントロールド セラピューティックス,インコーポレイテッド |
作用剤の徐放性組成物
|
DE19681560T1
(de)
|
1995-09-11 |
1998-08-20 |
Emisphere Tech Inc |
Verfahren zur Herstellung von omega-Aminoalkansäure-Derivaten aus Cycloalkanonen
|
JP2909418B2
(ja)
*
|
1995-09-18 |
1999-06-23 |
株式会社資生堂 |
薬物の遅延放出型マイクロスフイア
|
US5702717A
(en)
*
|
1995-10-25 |
1997-12-30 |
Macromed, Inc. |
Thermosensitive biodegradable polymers based on poly(ether-ester)block copolymers
|
US5665428A
(en)
*
|
1995-10-25 |
1997-09-09 |
Macromed, Inc. |
Preparation of peptide containing biodegradable microspheres by melt process
|
US6270795B1
(en)
|
1995-11-09 |
2001-08-07 |
Microbiological Research Authority |
Method of making microencapsulated DNA for vaccination and gene therapy
|
ATE192334T1
(de)
|
1995-11-09 |
2000-05-15 |
Microbiological Res Authority |
Mikroverkapselte dna zur impfung und gentherapie
|
DE19545257A1
(de)
|
1995-11-24 |
1997-06-19 |
Schering Ag |
Verfahren zur Herstellung von morphologisch einheitlichen Mikrokapseln sowie nach diesem Verfahren hergestellte Mikrokapseln
|
US5723508A
(en)
*
|
1996-01-25 |
1998-03-03 |
Northwestern University |
Method of fabricating emulsion freeze-dried scaffold bodies and resulting products
|
AU2595697A
(en)
*
|
1996-03-29 |
1997-10-22 |
Emisphere Technologies, Inc. |
Compounds and compositions for delivering active agents
|
US20020052310A1
(en)
*
|
1997-09-15 |
2002-05-02 |
Massachusetts Institute Of Technology The Penn State Research Foundation |
Particles for inhalation having sustained release properties
|
US5985309A
(en)
*
|
1996-05-24 |
1999-11-16 |
Massachusetts Institute Of Technology |
Preparation of particles for inhalation
|
US5874064A
(en)
|
1996-05-24 |
1999-02-23 |
Massachusetts Institute Of Technology |
Aerodynamically light particles for pulmonary drug delivery
|
US6652837B1
(en)
|
1996-05-24 |
2003-11-25 |
Massachusetts Institute Of Technology |
Preparation of novel particles for inhalation
|
JP2000512671A
(ja)
|
1996-06-14 |
2000-09-26 |
エミスフェアー テクノロジーズ インク |
マイクロカプセル化香料及び調製方法
|
EP0954301A4
(de)
|
1996-06-24 |
2006-03-08 |
Euro Celtique Sa |
Verfahren zur erzeugung einer sicheren lokalen anästhesie
|
ES2322405T3
(es)
|
1996-07-08 |
2009-06-19 |
Penwest Pharmaceuticals Co. |
Matriz de liberacion controlada para farmacos insolubles en dosis elevadas.
|
US6046187A
(en)
|
1996-09-16 |
2000-04-04 |
Children's Medical Center Corporation |
Formulations and methods for providing prolonged local anesthesia
|
CA2219698C
(en)
*
|
1996-10-31 |
2007-09-04 |
Takeda Chemical Industries, Ltd. |
Sustained-release preparation
|
US20020182258A1
(en)
*
|
1997-01-22 |
2002-12-05 |
Zycos Inc., A Delaware Corporation |
Microparticles for delivery of nucleic acid
|
US5990166A
(en)
|
1997-02-07 |
1999-11-23 |
Emisphere Technologies, Inc. |
Compounds and compositions for delivering active agents
|
US5879681A
(en)
|
1997-02-07 |
1999-03-09 |
Emisphere Technolgies Inc. |
Compounds and compositions for delivering active agents
|
US6313088B1
(en)
|
1997-02-07 |
2001-11-06 |
Emisphere Technologies, Inc. |
8-[(2-hydroxy-4-methoxy benzoyl) amino]-octanoic acid compositions for delivering active agents
|
US5876710A
(en)
|
1997-02-07 |
1999-03-02 |
Emisphere Technologies Inc. |
Compounds and compositions for delivering active agents
|
US5939381A
(en)
|
1997-02-07 |
1999-08-17 |
Emisphere Technologies, Inc. |
Compounds and compositions for delivering active agents
|
US6358504B1
(en)
*
|
1997-02-07 |
2002-03-19 |
Emisphere Technologies, Inc. |
Compounds and compositions for delivering active agents
|
US6126919A
(en)
|
1997-02-07 |
2000-10-03 |
3M Innovative Properties Company |
Biocompatible compounds for pharmaceutical drug delivery systems
|
US5804688A
(en)
|
1997-02-07 |
1998-09-08 |
Emisphere Technologies, Inc. |
Compounds and compositions for delivering active agents
|
US6060513A
(en)
|
1997-02-07 |
2000-05-09 |
Emisphere Technologies, Inc. |
Compounds and compositions for delivering active agents
|
US5863944A
(en)
|
1997-04-30 |
1999-01-26 |
Emisphere Technologies, Inc. |
Compounds and compositions for delivering active agents
|
US5962710A
(en)
|
1997-05-09 |
1999-10-05 |
Emisphere Technologies, Inc. |
Method of preparing salicyloylamino acids
|
ATE261721T1
(de)
*
|
1997-06-13 |
2004-04-15 |
Nanopharm Ag |
System zur gezielten wirkstoffzufuhr, verfahren zu seiner herstellung und verwendung
|
FR2764514B1
(fr)
|
1997-06-13 |
1999-09-03 |
Biopharmex Holding Sa |
Implant injectable en sous-cutane ou intradermique a bioresorbabilite controlee pour la chirurgie reparatrice ou plastique et la dermatologie esthetique
|
AU751267B2
(en)
|
1997-06-30 |
2002-08-08 |
Monsanto Technology Llc |
Microparticles containing agricultural active ingredients
|
AU739384B2
(en)
*
|
1997-07-02 |
2001-10-11 |
Euro-Celtique S.A. |
Prolonged anesthesia in joints and body spaces
|
US6376516B1
(en)
|
1997-08-19 |
2002-04-23 |
Emory University |
Noscapine and noscapine derivatives, useful as anticancer agents
|
US6673814B2
(en)
*
|
1997-08-19 |
2004-01-06 |
Emory University |
Delivery systems and methods for noscapine and noscapine derivatives, useful as anticancer agents
|
US7052678B2
(en)
|
1997-09-15 |
2006-05-30 |
Massachusetts Institute Of Technology |
Particles for inhalation having sustained release properties
|
US6201072B1
(en)
|
1997-10-03 |
2001-03-13 |
Macromed, Inc. |
Biodegradable low molecular weight triblock poly(lactide-co- glycolide) polyethylene glycol copolymers having reverse thermal gelation properties
|
US6117949A
(en)
*
|
1998-10-01 |
2000-09-12 |
Macromed, Inc. |
Biodegradable low molecular weight triblock poly (lactide-co-glycolide) polyethylene glycol copolymers having reverse thermal gelation properties
|
US6004573A
(en)
*
|
1997-10-03 |
1999-12-21 |
Macromed, Inc. |
Biodegradable low molecular weight triblock poly(lactide-co-glycolide) polyethylene glycol copolymers having reverse thermal gelation properties
|
US6056977A
(en)
*
|
1997-10-15 |
2000-05-02 |
Edward Mendell Co., Inc. |
Once-a-day controlled release sulfonylurea formulation
|
KR100289471B1
(ko)
*
|
1998-01-19 |
2001-09-17 |
김충섭 |
휀타닐계마취제의이식형서방성제제
|
KR19990065921A
(ko)
*
|
1998-01-19 |
1999-08-16 |
김충섭 |
항생제의서방성제제
|
US6099859A
(en)
*
|
1998-03-20 |
2000-08-08 |
Andrx Pharmaceuticals, Inc. |
Controlled release oral tablet having a unitary core
|
GB9810236D0
(en)
|
1998-05-13 |
1998-07-08 |
Microbiological Res Authority |
Improvements relating to encapsulation of bioactive agents
|
US6406719B1
(en)
|
1998-05-13 |
2002-06-18 |
Microbiological Research Authority |
Encapsulation of bioactive agents
|
US6264991B1
(en)
*
|
1998-08-18 |
2001-07-24 |
Southern Research Institute |
Compositions and methods for treating intracellular infections
|
US6956021B1
(en)
*
|
1998-08-25 |
2005-10-18 |
Advanced Inhalation Research, Inc. |
Stable spray-dried protein formulations
|
US7662409B2
(en)
*
|
1998-09-25 |
2010-02-16 |
Gel-Del Technologies, Inc. |
Protein matrix materials, devices and methods of making and using thereof
|
US20050147690A1
(en)
*
|
1998-09-25 |
2005-07-07 |
Masters David B. |
Biocompatible protein particles, particle devices and methods thereof
|
US6143314A
(en)
*
|
1998-10-28 |
2000-11-07 |
Atrix Laboratories, Inc. |
Controlled release liquid delivery compositions with low initial drug burst
|
US6365173B1
(en)
|
1999-01-14 |
2002-04-02 |
Efrat Biopolymers Ltd. |
Stereocomplex polymeric carriers for drug delivery
|
US6306425B1
(en)
|
1999-04-09 |
2001-10-23 |
Southern Research Institute |
Injectable naltrexone microsphere compositions and their use in reducing consumption of heroin and alcohol
|
US6287588B1
(en)
*
|
1999-04-29 |
2001-09-11 |
Macromed, Inc. |
Agent delivering system comprised of microparticle and biodegradable gel with an improved releasing profile and methods of use thereof
|
US6277401B1
(en)
*
|
1999-05-07 |
2001-08-21 |
U.S. Dermatologics, Inc. |
Drug delivery device
|
US6444223B1
(en)
*
|
1999-05-28 |
2002-09-03 |
Alkermes Controlled Therapeutics, Inc. |
Method of producing submicron particles of a labile agent and use thereof
|
KR20010002589A
(ko)
*
|
1999-06-16 |
2001-01-15 |
김윤 |
생리활성물질 함유 생분해성 고분자 마이크로스피어의 제조방법
|
CA2382821A1
(en)
*
|
1999-08-25 |
2001-03-01 |
Advanced Inhalation Research, Inc. |
Modulation of release from dry powder formulations
|
US6749835B1
(en)
|
1999-08-25 |
2004-06-15 |
Advanced Inhalation Research, Inc. |
Formulation for spray-drying large porous particles
|
US7678364B2
(en)
|
1999-08-25 |
2010-03-16 |
Alkermes, Inc. |
Particles for inhalation having sustained release properties
|
US20010036481A1
(en)
*
|
1999-08-25 |
2001-11-01 |
Advanced Inhalation Research, Inc. |
Modulation of release from dry powder formulations
|
FR2797784B1
(fr)
*
|
1999-08-27 |
2001-11-30 |
Mainelab |
Procede d'encapsulation de matieres actives par coacervation de polymeres en solvant organique non-chlore
|
WO2001022940A1
(en)
*
|
1999-09-30 |
2001-04-05 |
Edward Mendell Co., Inc. |
Sustained release matrix systems for highly soluble drugs
|
US20050037086A1
(en)
*
|
1999-11-19 |
2005-02-17 |
Zycos Inc., A Delaware Corporation |
Continuous-flow method for preparing microparticles
|
US6465425B1
(en)
|
2000-02-10 |
2002-10-15 |
Alkermes Controlled Therapeutics, Inc. |
Microencapsulation and sustained release of biologically active acid-stable or free sulfhydryl-containing proteins
|
US7018645B1
(en)
*
|
2000-04-27 |
2006-03-28 |
Macromed, Inc. |
Mixtures of various triblock polyester polyethylene glycol copolymers having improved gel properties
|
US6589549B2
(en)
|
2000-04-27 |
2003-07-08 |
Macromed, Incorporated |
Bioactive agent delivering system comprised of microparticles within a biodegradable to improve release profiles
|
AU2001268159B2
(en)
*
|
2000-06-02 |
2005-09-15 |
Eisai Inc. |
Delivery systems for bioactive agents
|
WO2002015888A1
(fr)
*
|
2000-08-24 |
2002-02-28 |
Santen Pharmaceutical Co., Ltd. |
Systeme de controle de liberation de medicament
|
SE517421C2
(sv)
|
2000-10-06 |
2002-06-04 |
Bioglan Ab |
Mikropartiklar, lämpade för parenteral administration, väsentligen bestående av stärkelse med minst 85 % amylopektin och med reducerad molekylvikt, samt framställning därav
|
JP2004510730A
(ja)
|
2000-10-06 |
2004-04-08 |
ヤゴテック アーゲー |
非経口的投与可能な制御放出微粒子調製物
|
SE517422C2
(sv)
|
2000-10-06 |
2002-06-04 |
Bioglan Ab |
Farmaceutiskt acceptabel stärkelse
|
US6866866B1
(en)
*
|
2000-11-03 |
2005-03-15 |
Andrx Labs, Llc |
Controlled release metformin compositions
|
SE518007C2
(sv)
|
2000-11-16 |
2002-08-13 |
Bioglan Ab |
Förfarande för framställning av mikropartiklar
|
US6767637B2
(en)
*
|
2000-12-13 |
2004-07-27 |
Purdue Research Foundation |
Microencapsulation using ultrasonic atomizers
|
AU2001298061A1
(en)
|
2000-12-13 |
2003-07-09 |
Purdue Research Foundation |
Microencapsulation of drugs by solvent exchange
|
WO2002049620A2
(en)
|
2000-12-21 |
2002-06-27 |
Inhale Therapeutic Systems, Inc. |
Induced phase transition method for the production of microparticles containing hydrophobic active agents
|
US20030125236A1
(en)
*
|
2000-12-29 |
2003-07-03 |
Advenced Inhalation Research, Inc. |
Particles for inhalation having rapid release properties
|
EP1345629A2
(de)
*
|
2000-12-29 |
2003-09-24 |
Advanced Inhalation Research, Inc. |
Inhalationspartikel mit verzögerter freigabe
|
US20020141946A1
(en)
*
|
2000-12-29 |
2002-10-03 |
Advanced Inhalation Research, Inc. |
Particles for inhalation having rapid release properties
|
JP2004521111A
(ja)
*
|
2001-01-25 |
2004-07-15 |
ユーロ−セルティーク,エス.エイ. |
局所麻酔薬および使用法
|
EP1408876A4
(de)
|
2001-06-22 |
2004-09-22 |
Durect Corp |
Koaxiale implantate nullter ordnung mit verlängerter freisetzung
|
US6703045B2
(en)
|
2001-08-21 |
2004-03-09 |
Council Of Scientific & Industrial Research |
Composition and method for maintaining blood glucose level
|
US7105181B2
(en)
|
2001-10-05 |
2006-09-12 |
Jagotec, Ag |
Microparticles
|
US8778322B2
(en)
*
|
2001-10-18 |
2014-07-15 |
Samyang Biopharmaceuticals Corporation |
pH responsive biodegradable polylactic acid derivatives forming polymeric micelles and uses thereof for poorly water soluble drug delivery
|
DK1455755T3
(da)
|
2001-11-20 |
2013-07-15 |
Civitas Therapeutics Inc |
Forbedrede partikelsammensætning til levering i lunge
|
WO2003043603A1
(en)
*
|
2001-11-20 |
2003-05-30 |
Advanced Inhalation Research, Inc. |
Particulate compositions for improving solubility of poorly soluble agents
|
FR2832312B1
(fr)
*
|
2001-11-21 |
2004-01-16 |
Inst Nat Sante Rech Med |
Procede de preparation de microparticules sans solvant toxique, microparticules obtenues selon ce procede, utilisations et compositions pharmaceutiques
|
HK1077740A1
(en)
|
2001-12-20 |
2006-02-24 |
Ct Ingenieria Genetica Biotech |
Use of epidermal growth factor in the manufacture of a pharmaceutical injection composition for preventing diabetic limb amputation
|
WO2003079990A2
(en)
*
|
2002-03-19 |
2003-10-02 |
Purdue Research Foundation |
Microencapsulation using ultrasonic atomizers
|
SE0201599D0
(sv)
|
2002-03-21 |
2002-05-30 |
Skyepharma Ab |
Microparticles
|
AU2003228666A1
(en)
*
|
2002-04-23 |
2003-11-10 |
Case Western Reserve University |
Lapachone delivery systems, compositions and uses related thereto
|
AU2003225212A1
(en)
*
|
2002-04-29 |
2003-11-17 |
Gel-Del Technologies, Inc. |
Biomatrix structural containment and fixation systems and methods of use thereof
|
AU2003241537A1
(en)
*
|
2002-05-23 |
2003-12-12 |
Andrx Corporation |
Biguanide formulations
|
US7157102B1
(en)
*
|
2002-05-31 |
2007-01-02 |
Biotek, Inc. |
Multi-layered microcapsules and method of preparing same
|
US7649023B2
(en)
*
|
2002-06-11 |
2010-01-19 |
Novartis Ag |
Biodegradable block copolymeric compositions for drug delivery
|
US20030228366A1
(en)
*
|
2002-06-11 |
2003-12-11 |
Chung Shih |
Reconstitutable compositions of biodegradable block copolymers
|
KR100897890B1
(ko)
*
|
2002-06-17 |
2009-05-18 |
인벤티아 헬스케어 피브이티. 엘티디. |
티아졸리딘디온 및 바이구아나이드를 함유하는 다층 정제및 그의 제조 방법
|
JP4530626B2
(ja)
*
|
2002-06-25 |
2010-08-25 |
武田薬品工業株式会社 |
徐放性組成物の製造方法
|
CA2490351C
(en)
|
2002-06-25 |
2011-11-01 |
Takeda Pharmaceutical Company Limited |
Process for producing sustained-release composition
|
GB2399084B
(en)
*
|
2002-07-30 |
2007-01-31 |
Univ Liverpool |
Porous beads and method of production thereof
|
ES2377318T3
(es)
|
2002-09-06 |
2012-03-26 |
Cerulean Pharma Inc. |
Polímeros a base de ciclodextrina para el suministro de los agentes terapéuticos enlazados covalentemente a ellos
|
AU2003274353B2
(en)
|
2002-10-24 |
2007-04-05 |
Merz Pharma Gmbh & Co. Kgaa |
Combination therapy using 1-aminocyclohexane derivatives and acetylcholinesterase inhibitors
|
AU2003289178A1
(en)
*
|
2002-12-04 |
2004-06-23 |
Yasuo Hatate |
Agricultural-chemical microcapsule preparation made by oil/oil liquid drying and process for producing the same
|
MXPA05012493A
(es)
|
2003-05-27 |
2006-05-25 |
Forest Laboratories |
Combinacion de un antagonista del receptor de nmda y un inhibidor selectivo de reabsorcion de serotonina para el tratamiento de depresion y otros trastornos de estado de animo.
|
US8465537B2
(en)
*
|
2003-06-17 |
2013-06-18 |
Gel-Del Technologies, Inc. |
Encapsulated or coated stent systems
|
CA2537315C
(en)
|
2003-08-26 |
2015-12-08 |
Gel-Del Technologies, Inc. |
Protein biomaterials and biocoacervates and methods of making and using thereof
|
US7311901B2
(en)
|
2003-10-10 |
2007-12-25 |
Samyang Corporation |
Amphiphilic block copolymer and polymeric composition comprising the same for drug delivery
|
ATE411015T1
(de)
*
|
2003-10-22 |
2008-10-15 |
Merz Pharma Gmbh & Co Kgaa |
Verwendung von 1-aminocyclohexan-derivaten zur modifizierung der abscheidung von fibrillogenen as peptiden in amyloidpathien
|
EP1691746B1
(de)
*
|
2003-12-08 |
2015-05-27 |
Gel-Del Technologies, Inc. |
Mukoadhäsive arzneimittelabgabevorrichtungen und verfahren zu ihrer herstellung und verwendung
|
WO2005070391A2
(en)
*
|
2004-01-21 |
2005-08-04 |
The School Of Pharmacy |
Method of producing microparticles
|
BRPI0507210A
(pt)
*
|
2004-02-23 |
2007-06-12 |
Euro Celtique Sa |
dispositivo que impede o uso indevido para administração transdérmica de opióide
|
WO2005110369A2
(en)
*
|
2004-04-30 |
2005-11-24 |
American Pharmaceutical Partners, Inc. |
Sustained-release microspheres and methods of making and using same
|
TW200616608A
(en)
*
|
2004-07-09 |
2006-06-01 |
Forest Laboratories |
Memantine as adjunctive treatment to atypical antipsychotics in schizophrenia patients
|
BRPI0515191A
(pt)
*
|
2004-08-13 |
2008-07-08 |
Angiotech Internac Ag |
composição farmacêutica, método para aumentar osso ou substituir perda óssea, método para reduzir a dor associada com cicatriz pós-cirúrgica, método para prevenir aderência cirúrgicas, método para aumento ou reparo de pele ou tecido, método para manter volume em fluido ocular durante cirurgia ocular, método para reduzir a dor associada com osteoartrite, método para tratar doença de refluxo gastroesofágico, método para tratar ou prevenir incontinência urinária, método para tratar ou prevenir incontinência fecal, implante método e dispositivo médico
|
AU2005286672B2
(en)
*
|
2004-09-23 |
2009-03-12 |
Merz Pharma Gmbh & Co. Kgaa |
Memantine for the treatment of childhood behavioral disorders
|
CN100349612C
(zh)
*
|
2005-02-05 |
2007-11-21 |
复旦大学 |
含葡激酶突变体的缓释微球制剂及其制备方法
|
WO2007005898A2
(en)
*
|
2005-07-05 |
2007-01-11 |
Cornell Research Foundation, Inc. |
Blocking leukocyte emigration and inflammation by interfering with cd99l2
|
US20070031611A1
(en)
*
|
2005-08-04 |
2007-02-08 |
Babaev Eilaz P |
Ultrasound medical stent coating method and device
|
US9101949B2
(en)
*
|
2005-08-04 |
2015-08-11 |
Eilaz Babaev |
Ultrasonic atomization and/or seperation system
|
US7896539B2
(en)
*
|
2005-08-16 |
2011-03-01 |
Bacoustics, Llc |
Ultrasound apparatus and methods for mixing liquids and coating stents
|
CA2800945C
(en)
*
|
2005-09-19 |
2017-12-05 |
Neuronascent, Inc. |
Methods and compositions for stimulating neurogenesis and inhibiting neuronal degeneration
|
US7942867B2
(en)
*
|
2005-11-09 |
2011-05-17 |
The Invention Science Fund I, Llc |
Remotely controlled substance delivery device
|
CU23388B6
(es)
*
|
2006-01-31 |
2009-07-16 |
Ct Ingenieria Genetica Biotech |
Composición farmacéutica de microesferas para prevenir la amputación del pie diabético
|
CU23558A1
(es)
|
2006-02-28 |
2010-07-20 |
Ct Ingenieria Genetica Biotech |
Compuestos análogos a los secretagogos peptidicos de la hormona de crecimiento
|
US9289196B2
(en)
|
2006-12-12 |
2016-03-22 |
Cook Medical Technologies Llc |
Hemostatic substance with a coating
|
US20080142616A1
(en)
*
|
2006-12-15 |
2008-06-19 |
Bacoustics Llc |
Method of Producing a Directed Spray
|
US8906431B2
(en)
*
|
2007-01-22 |
2014-12-09 |
Archer Daniels Midland Company |
Water dispersible compositions and methods of using the water dispersible compositions
|
JP2010516625A
(ja)
|
2007-01-24 |
2010-05-20 |
インサート セラピューティクス, インコーポレイテッド |
制御された薬物送達のためのテザー基を有するポリマー−薬物コンジュゲート
|
US7960139B2
(en)
|
2007-03-23 |
2011-06-14 |
Academia Sinica |
Alkynyl sugar analogs for the labeling and visualization of glycoconjugates in cells
|
ES2564826T3
(es)
|
2007-06-21 |
2016-03-29 |
Neuronascent, Inc. |
Métodos y composiciones para estimular neurogénesis e inhibir degeneración neuronal utilizando isotiazolopirimidinonas
|
US7780095B2
(en)
|
2007-07-13 |
2010-08-24 |
Bacoustics, Llc |
Ultrasound pumping apparatus
|
US7753285B2
(en)
|
2007-07-13 |
2010-07-13 |
Bacoustics, Llc |
Echoing ultrasound atomization and/or mixing system
|
JP5613053B2
(ja)
|
2007-09-12 |
2014-10-22 |
メルツ・ファルマ・ゲゼルシヤフト・ミト・ベシュレンクテル・ハフツング・ウント・コンパニー・コマンデイトゲゼルシヤフト・アウフ・アクティーン |
耳鳴を処置するための間欠療法
|
EP2237770A4
(de)
*
|
2007-12-26 |
2011-11-09 |
Gel Del Technologies Inc |
Biokompatible proteinteilchen, teilchenvorrichtungen und verfahren dafür
|
EP2085120A1
(de)
|
2008-02-01 |
2009-08-05 |
Merz Pharma GmbH & Co. KGaA |
Verwendung von Substanzen zur Behandlung zentraler und peripherer Insulinrezeptorbeeinträchtigung oder Insulinresistenz
|
WO2009100422A2
(en)
*
|
2008-02-08 |
2009-08-13 |
Zimmer, Inc. |
Drug delivery system comprising microparticles and gelation system
|
ES2442024T3
(es)
|
2008-07-15 |
2014-02-07 |
Academia Sinica |
Matrices de glucano sobre portaobjetos de vidrio revestidos con aluminio de tipo PTFE y métodos relacionados
|
WO2010009291A1
(en)
*
|
2008-07-16 |
2010-01-21 |
Surmodics Pharmaceuticals, Inc. |
Process for preparing microparticles containing bioactive peptides
|
WO2010057177A2
(en)
|
2008-11-17 |
2010-05-20 |
Gel-Del Technologies, Inc. |
Protein biomaterial and biocoacervate vessel graft systems and methods of making and using thereof
|
TWI432188B
(zh)
|
2008-12-19 |
2014-04-01 |
Merz Pharma Gmbh & Co Kgaa |
供治療發炎性皮膚疾病之1-胺基-烷基環己烷衍生物類
|
BRPI0923377A2
(pt)
|
2008-12-19 |
2015-07-21 |
Merz Pharma Gmbh & Co Kgaa |
Derivados de 1-amino-alquilciclohexano para o tratamento de doenças mediadas por mastócitos
|
KR101105292B1
(ko)
*
|
2009-06-05 |
2012-01-17 |
주식회사 리젠 바이오텍 |
생분해성 고분자 미세입자와 그의 제조방법
|
WO2011000564A1
(en)
|
2009-06-30 |
2011-01-06 |
Merz Pharma Gmbh & Co. Kgaa |
Eltoprazine for the treatment of drug addiction
|
WO2011000562A1
(en)
|
2009-06-30 |
2011-01-06 |
Merz Pharma Gmbh & Co. Kgaa |
Eltoprazine for the treatment of certain movement disorders
|
EP2448580A1
(de)
|
2009-06-30 |
2012-05-09 |
Merz Pharma GmbH & Co. KGaA |
Eltoprazin zur behandlung von angstzuständen
|
WO2011000563A1
(en)
|
2009-06-30 |
2011-01-06 |
Merz Pharma Gmbh & Co. Kgaa |
Eltoprazine for the treatment of weight disorders
|
CA2774015A1
(en)
|
2009-09-15 |
2011-03-24 |
Cerulean Pharma Inc. |
A cdp-camptothecin conjugate, particle or composition and uses thereof
|
CN101693177B
(zh)
*
|
2009-10-19 |
2012-07-04 |
上海现代药物制剂工程研究中心有限公司 |
基于超声技术的微球制备方法及其装置
|
BR112012012210B8
(pt)
*
|
2009-11-23 |
2021-05-25 |
Cerulean Pharma Inc |
conjugado de (cdp)-taxano de polímero contendo ciclodextrina, composição, composição farmacêutica, forma de dosagem, kit e uso de um conjugado de cdp-taxano
|
US11377485B2
(en)
|
2009-12-02 |
2022-07-05 |
Academia Sinica |
Methods for modifying human antibodies by glycan engineering
|
US10087236B2
(en)
|
2009-12-02 |
2018-10-02 |
Academia Sinica |
Methods for modifying human antibodies by glycan engineering
|
WO2011130332A1
(en)
|
2010-04-12 |
2011-10-20 |
Academia Sinica |
Glycan arrays for high throughput screening of viruses
|
WO2011146638A1
(en)
|
2010-05-18 |
2011-11-24 |
Cerulean Pharma Inc. |
Compositions and methods for treatment of autoimmune and other diseases
|
US20110294890A1
(en)
|
2010-05-28 |
2011-12-01 |
Merz Pharma Gmbh & Co. Kgaa |
Neramexane for the treatment or prevention of inner ear disorders
|
KR20120011344A
(ko)
*
|
2010-07-21 |
2012-02-08 |
에스케이케미칼주식회사 |
고분자 미립구의 제조방법 및 그 방법에 의해 제조된 고분자 미립구
|
WO2012023033A2
(en)
|
2010-08-18 |
2012-02-23 |
Purdue Pharma L.P. |
Improved peptide immunogens
|
WO2012098000A1
(en)
|
2011-01-20 |
2012-07-26 |
Merz Pharma Gmbh & Co. Kgaa |
Neramexane for the treatment or prevention of tinnitus related with stress or acute hearing loss
|
US9265815B2
(en)
|
2011-04-29 |
2016-02-23 |
Selecta Biosciences, Inc. |
Tolerogenic synthetic nanocarriers
|
WO2012171653A1
(en)
|
2011-06-15 |
2012-12-20 |
Merz Pharma Gmbh & Co. Kgaa |
Sarizotan for use in the treatment of attention deficit hyperactivity disorder (adhd)
|
US10130714B2
(en)
|
2012-04-14 |
2018-11-20 |
Academia Sinica |
Enhanced anti-influenza agents conjugated with anti-inflammatory activity
|
TW201412325A
(zh)
|
2012-06-20 |
2014-04-01 |
梅茲製藥有限兩合公司 |
用於治療患有青光眼及其他退化性眼疾之人類視力喪失的間隔醫療
|
AU2013306098A1
(en)
|
2012-08-18 |
2015-02-12 |
Academia Sinica |
Cell-permeable probes for identification and imaging of sialidases
|
WO2014055493A1
(en)
|
2012-10-02 |
2014-04-10 |
Cerulean Pharma Inc. |
Methods and systems for polymer precipitation and generation of particles
|
KR101481441B1
(ko)
|
2013-02-22 |
2015-01-13 |
주식회사 바임 |
폴리락트산(pla) 미세입자의 스프레이 공법에 따른 제조방법
|
JP7028556B2
(ja)
|
2013-05-03 |
2022-03-02 |
セレクタ バイオサイエンシーズ インコーポレーテッド |
特定の薬力学的有効期間および免疫寛容の誘発のための抗原を有する免疫抑制剤の送達
|
WO2014210397A1
(en)
|
2013-06-26 |
2014-12-31 |
Academia Sinica |
Rm2 antigens and use thereof
|
US9981030B2
(en)
|
2013-06-27 |
2018-05-29 |
Academia Sinica |
Glycan conjugates and use thereof
|
JP6486368B2
(ja)
|
2013-09-06 |
2019-03-20 |
アカデミア シニカAcademia Sinica |
改変されたグリコシル基を含む糖脂質を用いたヒトiNKT細胞の活性化
|
US10266488B2
(en)
|
2013-10-10 |
2019-04-23 |
Eastern Virginia Medical School |
4-((2-hydroxy-3-methoxybenzyl)amino)benzenesulfonamide derivatives as potent and selective inhibitors of 12-lipoxygenase
|
EP3094352B1
(de)
|
2014-01-16 |
2020-09-23 |
Academia Sinica |
Zusammensetzungen und verfahren zur behandlung und zum nachweis von krebs
|
US10150818B2
(en)
|
2014-01-16 |
2018-12-11 |
Academia Sinica |
Compositions and methods for treatment and detection of cancers
|
TWI687428B
(zh)
|
2014-03-27 |
2020-03-11 |
中央研究院 |
反應性標記化合物及其用途
|
TWI670078B
(zh)
|
2014-05-27 |
2019-09-01 |
中央研究院 |
抗cd20醣抗體及其用途
|
US10118969B2
(en)
|
2014-05-27 |
2018-11-06 |
Academia Sinica |
Compositions and methods relating to universal glycoforms for enhanced antibody efficacy
|
WO2015184002A1
(en)
|
2014-05-27 |
2015-12-03 |
Academia Sinica |
Anti-her2 glycoantibodies and uses thereof
|
JP6894239B2
(ja)
|
2014-05-27 |
2021-06-30 |
アカデミア シニカAcademia Sinica |
増強された抗体の有効性のための普遍的グリコフォームに関する組成物および方法
|
AU2015267044A1
(en)
|
2014-05-28 |
2016-12-15 |
Academia Sinica |
Anti-TNF-alpha glycoantibodies and uses thereof
|
MX2017002933A
(es)
|
2014-09-07 |
2017-05-30 |
Selecta Biosciences Inc |
Metodos y composiciones para atenuar las respuestas inmunes del vector de transferencia anti-viral de edicion del gen.
|
EP3191500A4
(de)
|
2014-09-08 |
2018-04-11 |
Academia Sinica |
Aktivierung menschlicher inkt-zellen mithilfe von glykolipiden
|
US9975965B2
(en)
|
2015-01-16 |
2018-05-22 |
Academia Sinica |
Compositions and methods for treatment and detection of cancers
|
US10495645B2
(en)
|
2015-01-16 |
2019-12-03 |
Academia Sinica |
Cancer markers and methods of use thereof
|
EP3789766A1
(de)
|
2015-01-24 |
2021-03-10 |
Academia Sinica |
Neuartige glycankonjugate und verfahren zur verwendung davon
|
WO2017041027A1
(en)
|
2015-09-04 |
2017-03-09 |
Obi Pharma, Inc. |
Glycan arrays and method of use
|
US10336784B2
(en)
|
2016-03-08 |
2019-07-02 |
Academia Sinica |
Methods for modular synthesis of N-glycans and arrays thereof
|
WO2017172990A1
(en)
|
2016-03-29 |
2017-10-05 |
Obi Pharma, Inc. |
Antibodies, pharmaceutical compositions and methods
|
US10980894B2
(en)
|
2016-03-29 |
2021-04-20 |
Obi Pharma, Inc. |
Antibodies, pharmaceutical compositions and methods
|
MY200886A
(en)
|
2016-04-22 |
2024-01-22 |
Obi Pharma Inc |
Cancer Immunotherapy by Immune Activation or Immune Modulation Via Globo Series Antigens
|
CN105963257B
(zh)
*
|
2016-04-26 |
2021-01-22 |
广州帝奇医药技术有限公司 |
一种缓释微粒的制备方法
|
AU2017302038B2
(en)
|
2016-07-27 |
2024-03-21 |
Obi Pharma, Inc. |
Immunogenic/therapeutic glycan compositions and uses thereof
|
KR102528998B1
(ko)
|
2016-07-29 |
2023-05-03 |
오비아이 파머 인코퍼레이티드 |
인간 항체, 제약 조성물 및 방법
|
US10538592B2
(en)
|
2016-08-22 |
2020-01-21 |
Cho Pharma, Inc. |
Antibodies, binding fragments, and methods of use
|
WO2018039465A1
(en)
*
|
2016-08-25 |
2018-03-01 |
Selecta Biosciences, Inc. |
Polyester polymer matrices for the delivery of allergens
|
TWI767959B
(zh)
|
2016-11-21 |
2022-06-21 |
台灣浩鼎生技股份有限公司 |
共軛生物分子、醫藥組成物及方法
|
WO2018169811A1
(en)
|
2017-03-11 |
2018-09-20 |
Selecta Biosciences, Inc. |
Methods and compositions related to combined treatment with anti-inflammatories and synthetic nanocarriers comprising an immunosuppressant
|
PE20210047A1
(es)
*
|
2018-06-12 |
2021-01-08 |
Farm Rovi Lab Sa |
Composicion inyectable
|
WO2020006176A1
(en)
|
2018-06-27 |
2020-01-02 |
Obi Pharma, Inc. |
Glycosynthase variants for glycoprotein engineering and methods of use
|
EP3791873A1
(de)
|
2019-09-16 |
2021-03-17 |
Universite De Bordeaux |
Verfahren zur behandlung und/oder vorbeugung von erkrankungen und symptomen im zusammenhang mit bkca- und/oder sk-kanalophathien
|
KR20210054660A
(ko)
*
|
2019-11-05 |
2021-05-14 |
주식회사 넥스트바이오메디컬 |
초기 방출 제어가 가능한 서방출성 미립구 및 이의 제조 방법
|
WO2022029220A1
(en)
|
2020-08-05 |
2022-02-10 |
Ellipses Pharma Ltd |
Treatment of cancer using a cyclodextrin-containing polymer-topoisomerase inhibitor conjugate and a parp inhibitor
|
WO2023054704A1
(ja)
*
|
2021-09-30 |
2023-04-06 |
日産化学株式会社 |
水溶性化合物とレシチンからなる複合体油中分散液の製造方法
|
WO2023056368A1
(en)
|
2021-09-30 |
2023-04-06 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Cyclic peptides as non-hormonal male contraceptive agents and methods of use thereof
|
CN115634213A
(zh)
*
|
2022-10-17 |
2023-01-24 |
浙江理工大学湖州研究院有限公司 |
一种具有生理温度智能响应的复合载药微球的制备方法
|